Search hospitals > Virginia > Virginia Beach
Urology of Virginia
Claim this profileVirginia Beach, Virginia 23462
Global Leader in Prostate Cancer
Global Leader in Urinary Incontinence
Conducts research for Bedwetting
Conducts research for Bladder Cancer
Conducts research for Overactive Bladder
90 reported clinical trials
4 medical researchers
Summary
Urology of Virginia is a medical facility located in Virginia Beach, Virginia. This center is recognized for care of Prostate Cancer, Urinary Incontinence, Bedwetting, Bladder Cancer, Overactive Bladder and other specialties. Urology of Virginia is involved with conducting 90 clinical trials across 61 conditions. There are 4 research doctors associated with this hospital, such as Michael Williams, Robert Given, MD, Kurt McCammon, MD, and Gregg Eure, MD.Area of expertise
1Prostate Cancer
Global LeaderStage IV
ATM positive
BRCA1 positive
2Urinary Incontinence
Global LeaderTop PIs
Michael WilliamsUrology of Virginia3 years of reported clinical research
Studies Chronic Obstructive Pulmonary Disease
Studies Liver Disease
5 reported clinical trials
6 drugs studied
Robert Given, MDUrology of Virginia, PLLC1 year of reported clinical research
Studies Prostate Cancer
3 reported clinical trials
4 drugs studied
Kurt McCammon, MDUrology of Virginia, PLLC5 years of reported clinical research
Studies Urinary Incontinence
Studies Stress Incontinence
1 reported clinical trial
2 drugs studied
Gregg Eure, MDUrology of Virginia, PLLC2 years of reported clinical research
Studies Benign Prostatic Hyperplasia
Studies Hyperplasia
1 reported clinical trial
2 drugs studied
Clinical Trials running at Urology of Virginia
Bladder Cancer
Prostate Cancer
Bladder Infection
Syndrome
Interstitial Cystitis
Somatoform Disorders
Allergy
Urinary Incontinence
Stress Incontinence
Stress Urinary Incontinence
Pembrolizumab + BCG
for Bladder Cancer
This study is evaluating whether a combination of a drug and a vaccine may be more effective than the vaccine alone in treating bladder cancer.
Recruiting2 awards Phase 39 criteria
TAR-200 + Cetrelimab vs BCG
for Bladder Cancer
The purpose of this study is to compare event-free survival (EFS) in participants with Bacillus Calmette-Guerin (BCG)-naive high-risk non-muscle invasive bladder cancer (HR-NMIBC), including high-grade papillary Ta, any T1, or carcinoma in situ (CIS), between TAR-200 plus cetrelimab (Group A) and TAR-200 alone (Group C) versus intravesical BCG (Group B).
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Urology of Virginia?
Urology of Virginia is a medical facility located in Virginia Beach, Virginia. This center is recognized for care of Prostate Cancer, Urinary Incontinence, Bedwetting, Bladder Cancer, Overactive Bladder and other specialties. Urology of Virginia is involved with conducting 90 clinical trials across 61 conditions. There are 4 research doctors associated with this hospital, such as Michael Williams, Robert Given, MD, Kurt McCammon, MD, and Gregg Eure, MD.